Foreign companies are increasingly rolling out new products targeting the growing elderly market in Vietnam.

Adding to the excitement of investments in the Vietnamese pharmaceutical sector, Celtrion Group from South Korea also found opportunities to join the game.

Since the beginning of the fourth quarter of 2018, pharmaceutical stocks have been forecast to thrive as bustling activities such as state divestitures, mergers and acquisitions (M&A), and notable investments from foreign healthcare firms are being announced left and right.

The massive entry of foreign pharmaceutical corporations, such as Sanofi, Taisho, and Abbott is creating considerable pressure for domestic pharmaceutical enterprises.

SUTHERLAND SPRINGS: A total of 26 people were killed during a gunman's shooting rampage at a Texas church during Sunday (Nov 5) services, Governor Greg Abbott said, warning the toll may rise.

The Ministry of Health recently presented the Excellence Award to Abbott Vietnam for its long-term commitment and significant support in improving healthcare in the country.

A company culture in which employees are nurtured and empowered is the reason not only for Abbott’s steady position among the Best Places to Work ranking in Vietnam but also for its stronger growth and presence in the country.

Abbott has recently been named among the Best Places to Work in Vietnam for the fourth consecutive year, once more recognising the company’s long-term commitment in fostering an environment where people are supported and empowered to reach their fullest potentials.

Innovation drives Abbott’s more than 125 years of “making an everlasting impact on human health.”

The global healthcare company Abbott is accompanying Vietnam in improving the quality of nutrition status through a partnership with the Ministry of Health (MoH).

With the wish to encourage people live a happy, healthy and full life, Abbott, a global healthcare company, has conducted a survey about what living a full life means and factors that help people live life to the fullest. Nearly two million people around the world have answered questions though online surveys, social channels and through many events in more than six months.

On August 30, global healthcare company Abbott announced the acquisition of Glomed Pharmaceutical Co., Inc. (Glomed), a leading Vietnamese pharmaceutical manufacturer.

A new study shows that people following this plan will have lower blood sugar levels and body weight, two key indicators for diabetes management.

As Vietnam has one of the fastest growing ageing populations in the world, more attention is being given to how to help adults live healthier lives.

It would only be appropriate to celebrate the Vietnam-US’ diplomatic relations by citing a vivid case study success. The 20-year journey of US-based leading healthcare company Abbott, as it built its presence in Vietnam, fits perfectly. Arriving in Vietnam in 1995, Abbott quickly partnered up with the local nutrition distributor 3A Nutrition to leverage its distribution expertise in a new market for quality science-based nutrition products. 18 years later, this business partnership has blossomed into an acquisition of 3A Nutrition by Abbott, resulting in a strong presence across all 63 cities and provinces in Vietnam. 3A Nutrition’s general director Douglas Kuo talked with VIR’s Hoang Anh about this growing integration.